Search

  1. Retinal Cell and Gene Therapy Innovation Summit

    Congress

    … Retinal Cell and Gene Therapy Innovation Summit For more information visit the conference … ProQR to present at the Retinal Cell and Gene Therapy Innovation Summit. …

  2. Always excited about RNA therapies

    Story

    … immune response.” What does your current role, Chief Innovation Officer, entail? “My responsibility is the … to (our CEO) Daniel that he wants to invest so much in innovation. About one third of the company is dedicated to …

    A photo of Gerard Platenburg

  4. Still going strong / One challenge after another

    Story

    There are currently around 160 people working at ProQR, but that wasn’t always the case. When Hee Lam Chan joined in 2013, she was only employee number six. As a result, she has seen the company grow and develop.

    A photo of Hee Lam Chan

  5. “A new way of designing medicines”

    Story

    Bart Klein was at the forefront of ProQR's Axiomer® RNA editing technology development. This platform technology makes it possible to use the cells own machinery to reverse mutations that cause a genetic disease. Read the interview.

    A photo of Bart Klein

  6. ProQR welcomes a new generation of scientists

    Blog

    … market and will hopefully contribute to bringing future innovations into the industry. Leiden student learning about … ProQR provided the students with tours of our innovative laboratories in Leiden, including the R&D, CMC and …

    A group of students outside the ProQR office